LOS ANGELES, CA – (NewMediaWire) – February 20, 2024 -With the Joint European Torus (JET) recently setting a new world record demonstrating the ability to reliably generate fusion energy using tritium and deuterium as their fuel source, and with preparations for ITER and so many other multi-million and multi-billion dollar fusion projects well underway, the use and market demand for tritium gas and tritium products are surging. US Nuclears (OTC-QB: UCLE) Overhoff Technology branch is the go-to solution for tritium monitoring instrumentation, with over 50 years of experience manufacturing tritium monitoring products for the DOE, DOD, military, nuclear power plants, and industrial manufacturers. In fact, Overhoff is now set to complete the shipment to a U.S. DOE facility totaling $421,500 for portable monitors used for measuring tritium in air.
One of the reasons that Overhoff has gained such an outstanding reputation manufacturing dependable tritium monitors is that it is exceptionally difficult to measure tritium accurately, and it requires decades of experience and specialized, finely tuned parts and procedures, all working perfectly in conjunction. As such, these specialty products command a high markup and good profits for unparalleled sensitivity, accuracy, and reliability.
Since it was founded back in 1972, Overhoff has worked with all the leading tritium users in the world, with extremely high customer retention due to the top performance and reliability of their products. Now, as fusion power ushers in a new, likely trillion-dollar industry, directly centered around tritium, Overhoff is poised to be the foremost provider for tritium monitoring equipment and is already working with several major fusion power projects.
Safe Harbor Act
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the companys website at www.usnuclearcorp.com
LOS ANGELES, CA, Jan. 30, 2024 (GLOBE NEWSWIRE) — via NewMediaWire –One of the most critical problems faced by the healthcare industry worldwide is the severe shortage of radionuclides for nuclear medicine, imaging, diagnosis, and treatment. US Nuclear’s (OTC-QB: UCLE) plan to bring medical isotopes to the market will reshape the landscape of healthcare and diagnostic imaging.
Medical isotopes play a key role in various diagnostic and therapeutic applications, aiding in the detection and treatment of numerous medical conditions. One of the most important functions of these isotopes is providing precise and accurate diagnostics for various medical conditions. From cancer detection to cardiovascular imaging, these isotopes enable healthcare professionals to visualize and assess the functioning of organs and tissues with exceptional detail and make a very accurate diagnosis. Without access to nuclear imaging, the patient runs the risk of a misdiagnosis or exploratory surgery which can easily damage the patient.
Medical isotope imaging provides crucial, life-saving information that no other scanners can. Medical isotopes provide a detailed ‘video’ of internal organs as they function, whereas other diagnostics provide just a still photo. For example, Tc-99m isotopes are used in myocardial perfusion imaging to assess the blood flow to the heart muscle, which is crucial to diagnosing and guiding treatment for cardiovascular heart disease, ultimately saving lives.
Currently, there is a severe shortage of medical isotopes. Worldwide, only six reactors produce these isotopes, and no production facility operates in the United States. The average age of these reactors is over 53 years, and licenses will expire on four of them in the next 10 years. If any one of these reactors shuts down for repairs or maintenance, the problem only gets worse. US Nuclear aims to solve this shortage by producing medical isotopes through clean fusion power at less than half the current cost since there are no expensive nuclear waste disposal costs involved.
The market for medical isotopes is around $10 billion today, but this can more than double with the new availability. With the increased medical isotope production capacity provided by US Nuclear, people across the world in other countries can have access to these critical tools, addressing healthcare disparities and improving lives.
How important is it that the world has medical scanners, and especially isotope scanners? There is a reason that rich and important people with serious health problems rush to America where they are confident of successful treatments. These successful treatments could not happen without ultra-accurate diagnoses that the top doctors with super scanners can make. Currently, only the US and Europe (18% of the world population) have commandeered almost 100% of these medical isotopes, but with US Nuclear’s dramatic increase in production and isotope generation capacity, the whole world over time can finally have access to advanced care and longer healthier lives.
Safe Harbor Act
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at www.usnuclearcorp.com
LOS ANGELES, CA, Jan. 22, 2024 (GLOBE NEWSWIRE) — viaNewMediaWire — Less than one month ago, US Nuclear Corp. (OTC-QB: UCLE) announced that MIFTI, a company that US Nuclear Corp has invested in, reported breakout fusion power test results on the 4 Mega Ampere Machine at L3 Harris Lab in San Leandro, California. At about the same time, Cleantech Group, a well-known expert in clean technologies, published a report, in which Dr. Hafiz Rahman, MIFTI President and Chief Scientist was quoted, “MIFTI’s recent experiments at L3 Harris produced a neutron yield of 10 to the 11th power; the highest level ever achieved by any private company in the world.”
With recent results of 150 billion neutrons per shot and predictions by leading computer predictive simulator codes of achieving greater then “break-even”, MIFTI expects that their Staged Z-Pinch fusion reactors will be able to generate abundant, low-cost, clean energy to the world’s electric power grids sooner than any other technology.
Radioisotopes are used in several industries, but most notably for advanced medical imaging and therapeutics to diagnose and treat cancer and heart disease. The market in the U.S. for medical radioisotopes is estimated at about $7.5 billion and it is important to note that this number could more than double if the supply was adequate, but it is not.
The DOE National Isotope Development Centerexplains, radioisotopes are produced in reactors by exposing suitable target materials to the intense reactor neutron flux for an appropriate time. While there is a global need for more radioisotope production, producing them requires large numbers of neutrons which are not easy to find.
Currently, the primary method for producing radioisotopes is by making them in outdated fission reactors. The industry is looking for other neutron sources to produce these radioisotopes, but they are difficult to find. One key drawback to the production of radioisotopes from fission reactors is that this method creates very costly nuclear waste disposal costs which are a key component in the pricing of today’s radioisotopes.
The required number of radioisotopes to make radioisotopes is 10 to the 12th or about 1 trillion neutrons. MIFTI’s recent breakthrough was very close (10 to the 11th) to that required number and is going back to L3 Harris in February 2024 for the next round of testing. This next experiment will be using substantially more power than previous testing and is predicted by the top predictive computer codes such as MACH2, Hydra, Flash and Chicago to be able to meet production requirements for abundant, low-cost radioisotope production.
A key differentiator of MIFTI’s fusion technology to produce neutrons is that it has the potential to produce radioisotopes at an estimated less than half the current cost because there are no high-priced nuclear waste disposal costs. And the machines are projected to be smaller and safer.
MIFTI is working on designing, proving, and building fusion generators that can supply enormous, low-cost, clean energy to the electric power grid and also produce medical radioisotopes. Since the machines for radioisotopes are smaller, less costly, and the fastest to build, radioisotope production is the quickest and lowest hanging fruit for this technology. The estimated timing to production and sale of radioisotopes is under 2 years from the date of final funding because a great deal of the design work and testing for the first machines has already been done. With successful world record neutron production in the past year of testing, US Nuclear Corp is targeting the medical radioisotope market for the first use of this breakthrough technology. U.S. Nuclear Corp. will provide updates as available.
Safe Harbor Act
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at www.usnuclearcorp.com.
WEST PALM BEACH, Fla., Jan. 16, 2024 (GLOBE NEWSWIRE) — Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer, Seamus Lagan provides the following message to shareholders.
Dear Fellow Shareholders,
As we begin 2024, I want to provide an update on some of our recent accomplishments and outline our plans for the future.
Our efforts in recent years to build and sustain a viable business model for our healthcare services operations have gained momentum. 2023 was a significant year for the Company both operationally and financially. We are making great strides on both fronts as we seek to build a strong foundation to serve our patients and our communities and position the Company for long-term growth.
2023 Operational Highlights
Established robust inpatient services at our flagship hospital, Big South Fork Medical Center.
Achieved growth in emergency room and outpatient services.
Commenced a swing bed service line.
Opened a behavioral health treatment facility offering residential and inpatient detox services and outpatient, office-based opiate treatment services via our wholly-owned subsidiary Myrtle Recovery Centers, Inc.
2023 Financial Highlights
Significant net revenue growth.
Debt reduction.
Debt restructuring.
InnovaQor, Inc. (OTC: INQR) update.
Established robust inpatient services. 2023 saw inpatient admissions increase by over 75% compared to 2022; this service line was effectively shuttered in late 2020 and early 2021 due to COVID-19 and related matters. In fact, inpatient admissions in 2023 were stronger than in 2019 (pre COVID-19). Vibrant inpatient services mean that most patients who come to our emergency room for treatment no longer need to be transferred to other regional hospitals for inpatient care.
Growth in emergency room and outpatient services. Our ER and outpatient services activity increased by 4% and 8% year-over-year respectively demonstrating the continued, stable demand for such services.
Commenced a swing bed service line. The hospital initiated a swing bed service line—a valuable, profitable service that is helpful to the local communities and other nearby providers.
Opening of a behavioral health treatment facility. We formed a new subsidiary, Myrtle Recovery Centers, Inc., and opened residential and inpatient detox services and outpatient, office-based opiate treatment services at our Big South Fork Medical Center campus in August 2023.
Significant net revenue growth. Growth in net revenues in the third quarter 2023 compared to the prior year’s quarter was 25% reflecting increased patient activity at the hospital and higher reimbursement rates. The Company reported net revenues of approximately $14.8 million for the nine-months ending September 30, 2023 and, therefore, expects to report a significant increase in full year net revenues compared to approximately $13.0 million in net revenues that were reported for 2022.
Debt reduction. Debt from year-end 2022 to September 30, 2023 was reduced from $14.5 million to $11.6 million—a reduction of $2.9 million through debt pay-downs and/or negotiated settlements.
Debt restructuring. We successfully negotiated a debt restructuring with a key institutional lender holding $8.2 million of secured debt in October 2023 to extend the maturity to December 2025 and implement other modifications which waived historical defaults thereby saving default interest in future periods. This restructuring will further improve our balance sheet at December 31, 2023.
InnovaQor, Inc. (OTC: INQR) update. InnovaQor in 2023 initiated and continues to develop Curallo, a next-generation communication platform for medical professionals that will offer subscription-based services. We believe the success of InnovaQor will benefit Rennova and its shareholders.
Moving forward
We began 2024 with positive operational momentum and seek to build on recent achievements to: (i) further expand our healthcare services offerings in the communities we serve, (ii) consider options to reopen or create value from our closed hospital property, (iii) continue to improve our balance sheet and overall financial condition, and (iv) further reduce litigation and related costs.
Consideration for expansion of healthcare services will include our hospital-based services and behavioral health services provided by Myrtle Recovery Centers, Inc. We continue to evaluate the best ways to create value for Rennova and its shareholders from our investments in InnovaQor, Inc.
We appreciate the support of our shareholders and look forward to increasing shareholder value in 2024.
Best regards,
Seamus Lagan
Chief Executive Officer
About Rennova Health, Inc.
Rennova Health, Inc. (“Rennova,”) is a provider of health care services. The Company owns one operating hospital in Oneida, Tennessee known as Big South Fork Medical Center, a hospital located in Jamestown, Tennessee that it plans to reopen, and a rural clinic in Kentucky, an alcohol and drug treatment facility and OBOT operated by Myrtle Recovery Centers, Inc.
Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company’s most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.
LOS ANGELES, CA, Jan. 16, 2024 (GLOBE NEWSWIRE) — viaNewMediaWire — US Nuclear’s (OTC-QB: UCLE) in depth knowledge and experience in designing and manufacturing nuclear systems, along with its strategic cooperation and investment in the leading fusion power and desalination developers, offers triple solution to three of the biggest global challenges of clean energy, water, and food scarcity. Recent major developments in fusion power generation show that a world with fusion power is coming, and it will truly revolutionize our landscape, providing unlimited access to clean energy and water for the world.
Cheap, abundant, green fusion electric power plants, both large and small scale, provides power needed for growing populations and fast-growing industrialization. An energy crisis is making this winter especially cold as people struggle to afford the costs of oil and gas for heating—fusion power will solve issues like these and do so with zero emissions.
Super-efficient hydroponic vertical farms powered by fusion will provide enough food for the world and drastically reduce the food sector’s carbon emissions in the process. Food can be grown efficiently indoors, avoiding complications of soil, weather, and time of year.
Powering existing energy-hungry desalination plants, as well as the new desalination plants built by USN and partner Arbok Nuclear. More than 33% of the population (over 2.7 billion people) do not have adequate access to safe drinking water, and as access to fresh, clean water dries up, attention has focused on desalination technology. The drawback of desalination has been the huge amount of energy it requires, but with fusion power, energy costs will be cut to nearly zero, providing unlimited access to clean water. The surplus water will enable vast carbon sequestration projects across the world, planting forests to pull CO2 out of the air and combat pollution and climate change.
US Nuclear Corp. remains dedicated to advancing the frontiers of nuclear technology and is poised to play a pivotal role in shaping a future where clean energy and water resources are readily available to all.
Safe Harbor Act
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “will,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that will cause the actual results to differ materially from the expected results.
Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at www.usnuclearcorp.com.
CONTACT:
US Nuclear Corp. (OTC-QB: UCLE)
Robert I. Goldstein, President, CEO, and Chairman
Michael Hastings, Chief Financial Officer
(818) 883 7043
Email: info@usnuclearcorp.com http://usnuclearcorp.com
Highlights include record revenue so far this year, asset sale of $4 million, strengthened balance sheet, elimination of convertible debt, and a strong pipeline for 2024
SAN ANTONIO, Jan. 04, 2024 (GLOBE NEWSWIRE) — C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a developer and marketer of glass strengthening solutions for enhanced safety, announced today its 2023 highlights. The Company also participated in an investor podcast to discuss 2023 achievements and 2024 goals, which can be heard here: https://www.youtube.com/watch?v=64_UULOJ3zM
2023 Highlights
Revenue was over $1.7 million for the first nine months of 2023, exceeding revenue for the first nine-month period of any prior year, even without the contribution of any revenue from our previously owned C-Bond nanoShield product, which we sold in the second quarter of 2023
C-Bond sold its C-Bond nanoShield windshield strengthener and related automotive assets for more than $4 million
Company strengthened its balance sheet, paid off debt, and restructured its last remaining convertible note to eliminate convertible features and stop accruing interest
C-Bond filed to officially establish Patriot Glass Solutions as a subsidiary as a result of expanding operations and strong revenue growth, with its products now installed in 162 schools in Texas as well as many other commercial facilities
Strong pipeline of purchase orders already received for 2024
“2023 was a transformational year for us as we sold the C-Bond nanoShield business, allowing us to strengthen our balance sheet and focus on our core Patriot Glass Solutions products,” stated Scott R. Silverman, Chairman and CEO of the Company. “Further growing our Patriot Glass Solutions subsidiary and our best-in-class products is our primary goal for 2024. We already have a solid pipeline of projects lined up to begin in 2024 and we will continue to expand by getting our ballistic and security film products specified by architects and growing our dealer network across the country.”
Patriot Glass Solutions protects personal, commercial and government property from looting, smash-and-grabs, break-ins, and gunfire. Its leading products are C-Bond BRS, a ballistic-resistant film system, and C-Bond Secure, a multi-purpose glass strengthening primer and window film mounting solution that deters forced entry.
To see a demonstration of Patriot Glass Solutions’ security products, watch our video at: https://bit.ly/3l93oZV
For more information about Patriot Glass Solutions’ products, please call 844-602-2663 or email Michael Wanke at mike@patriotglasssolutions.com.
Statements in this press release about our future expectations, including the likelihood that we already have a solid pipeline of projects lined up to begin in 2024 and we will continue to expand by getting our ballistic and security film products specified by architects and growing our dealer network across the country; any forward-looking statements contained in the podcast interview; constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and our actual results could differ materially from expected results. These risks and uncertainties include, without limitation, the Company’s ability to successfully commercialize its products; the likelihood that schools will comply with the Texas Education Agency’s rule on school safety; the Company’s and its customers’ ability to source materials; construction delays; film delays; the Company’s ability to raise capital; regulatory risks; as well as other risks. Additional information about these and other factors may be described in the Company’s filings with the Securities and Exchange Commission (“SEC”) including its Form 10-K filed on March 31, 2023, its Forms 10-Q filed on November 14, 2023, August 14, 2023, and May 15, 2023, and in future filings with the SEC. The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.
Phoenix, January 3rd, 2024 (Accesswire) — The Stock Day Podcast welcomed C-Bond
Systems, Inc. (OTC PINK:CBNT)("the Company"), a San Antonio-based
nanotechnology company and marketer of the patented C-Bond technology, which is
proven to strengthen glass for architectural applications. CEO of the Company, Scott R.
Silverman, joined Stock Day host Matthew Dunehoo.
Silverman began the interview by discussing the Company’s 2023 highlights. “We
entered 2023 looking to grow significantly with both our top-line and bottom-line related
to the growth of our Patriot Glass subsidiary,” shared Silverman, before elaborating on
the industry-leading solutions developed by this division, which are designed to delay
and prevent break-ins and shootings. “Going into the summer of 2023, we knew there
would be a significant opportunity in the school space, particularly in Texas,” he said,
noting new state mandates and guidelines regarding public schools and window
reinforcement solutions. “This is going to continue to expand in 2024 across other parts
of the country as well.”
“All-in-all, 2023 was a very successful year,” continued Silverman. “As you know our 3rd
quarter was a record revenue quarter, by far, with well over $800,000,” he said. “We
expect to be led into a very strong 2024 from a revenue growth perspective.”
“The other highlight of 2023 was the sale of our automotive division, which we sold for
$4 million in cash,” shared Silverman. “This strengthened our balance sheet, paid off
over $2 million in debt, and gave us working capital in order to go out there and grow
the Patriot Glass Solutions division,” he continued. “2023 was by far the best year that I
have been at C-Bond and the best year in C-Bond’s history.”
“What can we expect for catalysts in 2024?”, asked Dunehoo. Silverman explained that
the Company now has an established pipeline of contracts and projects, including
numerous multi-year contracts. “We have active jobs for the 4th quarter, which should
yield very strong revenue production, but we also have a backlog going into 2024.”
“Which catalysts do you believe will be the most inspirational to the investing public at
large?”, asked Dunehoo. “The revenue growth, as well as our established pipeline
within the school, commercial, and government sectors, as well as the strengthening of
our balance sheet by paying off our convertible debt in the sale of our automotive
division,” said Silverman. “Going into 2024, we hope to grow organically and perhaps externally too through partnership or acquisition to lead us into a position where 2024
revenues will be substantially higher than 2023 revenues.”
To close the interview, Silverman thanked shareholders for their continued support and
encouraged listeners to keep up-to-date on the Company’s growing portfolio as they
continue to expand throughout the school, commercial, and government sectors.
To hear Scott Silverman’s entire interview, follow the link to the podcast here:
Investors Hangout is a proud sponsor of “Stock Day,” and Stock Day Media encourages
listeners to visit the company’s message board at https://investorshangout.com/
About C-Bond
C-Bond Systems, Inc. (OTC PINK:CBNT) is a San Antonio-based nanotechnology
company and marketer of the patented C-Bond technology, which is proven to
strengthen glass for architectural applications. The Company's Patriot Glass Solutions
subsidiary sells ballistic-resistant glass solutions and forced entry deterrent solutions to
private enterprises, schools, and government agencies. For more information, please
visit our websites: www.cbondsystems.com, www.patriotglasssolutions.com, Facebook:
https://www.facebook.com/cbondsys/ and Twitter: https://twitter.com/CBondSys and
https://twitter.com/Patriot_Glass.
Forward-Looking Statements
Statements in this press release about the Company's future expectations, including the
likelihood that school mandates are going to continue to expand in 2024 across other
parts of the country as well; the likelihood that we will be led into a very strong 2024
from a revenue growth perspective; the likelihood that the Company will continue to
grow and expand across the country; the likelihood that going into 2024, we hope to
grow organically and perhaps externally too through partnership or acquisition to lead
us into a position where 2024 revenues will be substantially higher than 2023 revenues;
constitute "forward-looking statements" within the meaning of Section 27A of the
Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that
term is defined in the Private Litigation Reform Act of 1995. Such forward-looking
statements involve risks and uncertainties and are subject to change at any time, and
our actual results could differ materially from expected results. These risks and
uncertainties include, without limitation, the Company's ability to successfully
commercialize its products; the Company's and its customers' ability to source
materials; construction delays; film delays; the Company's ability to raise capital;
regulatory risks; as well as other risks. Additional information about these and other
factors may be described in the Company's filings with the Securities and Exchange
Commission ("SEC") including its Form 10-K filed on March 31, 2023, its Forms 10-Q
filed on November 14, 2023, August 14, 2023, and May 15, 2023, and in future filings
with the SEC. The Company undertakes no obligation to update or release any
revisions to these forward-looking statements to reflect events or circumstances after
the date of this statement or to reflect the occurrence of unanticipated events, except as
required by law.
CONTACT: Contact: Allison Tomek C-Bond Systems
atomek@cbondsystems.com
About The “Stock Day” Podcast
Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and
Micro-Cap companies. It educates investors while simultaneously working with penny
stock and OTC companies, providing transparency and clarification of under-valued,
under-sold Micro-Cap stocks of the market. Stock Day provides companies with
customized solutions to their news distribution in both national and international media
outlets. The Stock Day Podcast is the number one radio show of its kind in America.
LOS ANGELES, CA, Dec. 26, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – As US Nuclear (OTC-QB: UCLE) has reported in previous releases, Magneto Inertial FusionTechnology Inc (MIFTI) is a leader in fusion power development and has already achieved extraordinary success with their 1-MegaAmp prototype fusion generator. Now, US Nuclear is excited to announce that MIFTI, led by president and chief scientist Dr. Hafiz Rahman, has recently demonstrated its fusion technology at the L3 Harris Lab in San Leandro, California, where they produced an amazing yield of 150 billion neutrons, which meets all advanced computer code predictions. This is 10,000 times higher than achieved by any other private company in the world.
Advanced simulations have shown that scaling up MIFTI’s fusion generator to 10 Mega Amps should achieve net energy gain and also allow for the commercial production of medical isotopes that are desperately needed for hospital cancer scanning. US Nuclear is a partner, investor, and possible prime contractor for MIFTI’s fusion power generator, and is looking forward to further developments.
Continuing breakthroughs in technology and a large influx of funding have rapidly accelerated fusion power development. Investment in the global fusion industry has skyrocketed, reaching a cumulative $6.21 billion, up from 4.8 billion just a year ago. Last year, Lawrence Livermore National Lab were the first to achieve positive net energy gain, paving the way towards the commercialization of fusion power, and Microsoft recently signed the world’s first deal to purchase commercial fusion energy from Helion Energy starting in 2028. MIFTI is unique in that they are the only company in the world that has developed a staged Z-pinch fusion method to the point of massive energy emission via neutron production. Their special approach has many advantages that will make them a leader in fusion power generation.
MIFTI was founded in 2008 by scientists from UC Irvine, who have spent over 25 years researching and developing their special Staged Z-pinch fusion technology. Years of experimentation, understanding, and advanced modeling have shown that MIFTI’s Z-pinch fusion approach can solve the world’s energy problems by providing a net energy gain from ten to fifty times the energy used to drive the process. In addition, the staged Z-pinch approach is very flexible and can be used for numerous applications, including the production of medical scanning isotopes and solving the worldwide multi-billion-dollar medical shortage.
Safe Harbor Act
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at www.usnuclearcorp.com
Based on New Booked Orders and Committed Orders Putting AITX Over the $5 Million Milestone
Detroit, Michigan, Dec. 21, 2023 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc., (the “Company”) (OTCPK:AITX), a global leader in AI-driven security and productivity solutions for enterprise clients along with its wholly owned subsidiary, Robotic Assistance Devices, Inc. (RAD), today announced that with the receipt of several expansion orders from existing clients, the Company anticipates passing the $5 million recurring annual revenue milestone upon all booked and anticipated orders being successfully deployed and accepted by the customers. This is as of December 20, 2023.
With a cashflow break-even estimated at $7 million in annual recurring revenue the Company appears to be fulfilling its growth forecast as described at the November 3, 2023 Investors Conference that is available on the AITX YouTube channel. The Company noted that revenues from implementation, training and monitoring are not included in the $7 million recurring revenue goal.
Mark Folmer, CPP, PSP, FSyI, President of RAD commented, “We are profoundly grateful for the dedication of our team and the trust of our customers that have brought us to the cusp of achieving $5 million in recurring annual revenue. It’s been a journey to get to this point and I’m looking forward to fulfilling our 2024 projections. This remarkable milestone fills us with optimism as we envision an even brighter future, fueled by the unwavering support of our valued clients and the relentless pursuit of excellence from our entire organization.”
Steve Reinharz, CEO of AITX and RAD noted, “It’s said the first $5 million in annual recurring revenue is the hardest. I’m excited to share updated projections next year of our continued growth forecasts.”
Recurring revenues offer a consistent and reliable income stream that businesses can depend on, providing financial stability and the ability to plan for the future. Unlike sales revenue, which can fluctuate unpredictably, recurring revenues foster lasting customer relationships and sustainable growth opportunities.
Achieving recurring monthly revenue (RMR) is contingent upon several factors, including RAD producing and delivering the ordered products, customer acceptance of said deliveries, proper operation, client acceptance, client payment and any other issues that could interfere with these activities. RMR is money earned from customers who pay for a subscription to a service or product. RAD’s solutions are generally offered as a recurring monthly subscription, typically with a minimum 12-month subscription contract.
AITX, through its subsidiary, Robotic Assistance Devices, Inc. (RAD), is redefining the $25 billion (US) security and guarding services industry through its broad lineup of innovative, AI-driven Solutions-as-a-Service business model. RAD solutions are specifically designed to provide cost savings to businesses of between 35%-80% when compared to the industry’s existing and costly manned security guarding and monitoring model. RAD delivers these tremendous cost savings via a suite of stationary and mobile robotic solutions that complement, and at times, directly replace the need for human personnel in environments better suited for machines. All RAD technologies, AI-based analytics and software platforms are developed in-house.
RAD has a prospective sales pipeline of over 35 Fortune 500 companies and numerous other client opportunities. RAD expects to continue to attract new business as it converts its existing sales opportunities into deployed clients generating a recurring revenue stream. Each Fortune 500 client has the potential of making numerous reorders over time.
About Artificial Intelligence Technology Solutions (AITX)
AITX is an innovator in the delivery of artificial intelligence-based solutions that empower organizations to gain new insight, solve complex challenges and fuel new business ideas. Through its next-generation robotic product offerings, AITX’s RAD, RAD-M and RAD-G companies help organizations streamline operations, increase ROI, and strengthen business. AITX technology improves the simplicity and economics of patrolling and guard services and allows experienced personnel to focus on more strategic tasks. Customers augment the capabilities of existing staff and gain higher levels of situational awareness, all at drastically reduced cost. AITX solutions are well suited for use in multiple industries such as enterprises, government, transportation, critical infrastructure, education, and healthcare. To learn more, visit www.aitx.ai, www.radsecurity.com, www.stevereinharz.com, www.radgroup.ai, www.raddog.ai, and www.radlightmyway.com, or follow Steve Reinharz on Twitter @SteveReinharz.
CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS
The information contained in this publication does not constitute an offer to sell or solicit an offer to buy securities of Artificial Intelligence Technology Solutions, Inc. (the “Company”). This publication contains forward-looking statements, which are not guarantees of future performance and may involve subjective judgment and analysis. As such, there are no assurances that the Company will meet its expectations with respect to its future sales volume or becoming cash flow positive. The information provided herein is believed to be accurate and reliable, however the Company makes no representations or warranties, expressed or implied, as to its accuracy or completeness. The Company has no obligation to provide the recipient with additional updated information. No information in this publication should be interpreted as any indication whatsoever of the Company’s future revenues, results of operations, or stock price.
Detroit, Michigan, Dec. 14, 2023 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc., (the “Company”) (OTCPK:AITX), a global leader in AI-driven security and productivity solutions for enterprise clients along with its wholly owned subsidiary, Robotic Assistance Devices, Inc. (RAD), today announced the signing of 5 new authorized dealers.
“RAD’s dealer channel continues to attract the most forward-looking and innovative market disruptors, just like RAD,” said Troy McCanna, Senior VP of Revenue Operations at RAD. “We’ve now got the broad national and tight regional coverage we could ask for. What we need to do now is to help pour fuel on their fire and greatly expand their business opportunities.”
Headquartered in Downers Grove, Illinois, with offices in Chicago’s River North neighborhood, Springfield and Michigan, P4 Security Solutions (P4S) and P4 Protective Services (P4P) are sister companies that provide full-service integrated guarding, remote monitoring, Off-Duty Police Services, Executive Protection, Corporate Risk Management training, and consultation. P4 provides best-in-class security solutions to a range of vertical markets in different industries and is the fastest-growing, privately held security firm in the nation.
Vista International Security, headquartered in Southfield, Michigan services the nation with technology-driven guarding solutions.
IT Installs, located in Sarasota, Florida provides nationwide installation services for all types of IT and security services equipment. IT Installs specializes in helping retailers and medical offices open new locations and upgrade existing locations.
Reliance Security, a veteran-founded small business, is Nevada’s leader in providing cutting-edge security services and solutions for individuals, businesses and events located in Las Vegas, North Las Vegas, Henderson, Boulder County, Clark County, Pahrump and Reno.
“We are tremendously excited about presenting RAD’s AI-powered solutions to our clients and prospects throughout Nevada,” said Joel Logan, Chief Executive Officer at Reliance Security. “Our clients are eager to embrace new tech that works and saves them money.”
The fifth new dealer will be revealed at a later date.
When it comes to demonstrating RAD solutions to clients and prospects, RAD authorized dealers must obtain a demonstration unit. McCanna added, “Most new dealers acquire a ROSA™ system, it’s RAD’s most popular solutions and demonstrates effortlessly, showcasing RAD’s distinctive ‘security-in-a-box’ simplicity.”
McCanna noted that P4 Security Solutions also ordered a RIO™ 360 in addition to their ROSA demonstration unit.
Steve Reinharz, CEO of AITX and RAD commented, “I get the sense that with every new dealer we add to our distribution channel, the entire industry moves that much closer to accepting that RAD represents the future. Adopting low-cost, hi-performance, AI-powered solutions is the answer.”
With the addition of these new authorized dealers, RAD’s dealer network has expanded to 69, covering the US, Canada, and the European Union.
ROSA is a multiple award-winning, compact, self-contained, portable, security and communication solution that can be installed and activated in about 15 minutes. ROSA’s AI-driven security analytics include human, firearm, vehicle detection, license plate recognition, responsive digital signage and audio messaging, and complete integration with RAD’s software suite notification and autonomous response library. Two-way communication is optimized for cellular, including live video from ROSA’s high-resolution, full-color, always-on cameras. RAD has published five Case Studies detailing how ROSA has helped eliminate instances of theft, trespassing and loitering at hospital campuses, multi-family communities, car rental locations and construction sites across the country.
AITX, through its subsidiary, Robotic Assistance Devices, Inc. (RAD), is redefining the $25 billion (US) security and guarding services industry through its broad lineup of innovative, AI-driven Solutions-as-a-Service business model. RAD solutions are specifically designed to provide cost savings to businesses of between 35%-80% when compared to the industry’s existing and costly manned security guarding and monitoring model. RAD delivers these tremendous cost savings via a suite of stationary and mobile robotic solutions that complement, and at times, directly replace the need for human personnel in environments better suited for machines. All RAD technologies, AI-based analytics and software platforms are developed in-house.
RAD has a prospective sales pipeline of over 35 Fortune 500 companies and numerous other client opportunities. RAD expects to continue to attract new business as it converts its existing sales opportunities into deployed clients generating a recurring revenue stream. Each Fortune 500 client has the potential of making numerous reorders over time.
About Artificial Intelligence Technology Solutions (AITX)
AITX is an innovator in the delivery of artificial intelligence-based solutions that empower organizations to gain new insight, solve complex challenges and fuel new business ideas. Through its next-generation robotic product offerings, AITX’s RAD, RAD-M and RAD-G companies help organizations streamline operations, increase ROI, and strengthen business. AITX technology improves the simplicity and economics of patrolling and guard services and allows experienced personnel to focus on more strategic tasks. Customers augment the capabilities of existing staff and gain higher levels of situational awareness, all at drastically reduced cost. AITX solutions are well suited for use in multiple industries such as enterprises, government, transportation, critical infrastructure, education, and healthcare. To learn more, visit www.aitx.ai, www.radsecurity.com,www.stevereinharz.com, www.radgroup.ai, www.raddog.ai, and www.radlightmyway.com, or follow Steve Reinharz on Twitter @SteveReinharz.
CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS
The information contained in this publication does not constitute an offer to sell or solicit an offer to buy securities of Artificial Intelligence Technology Solutions, Inc. (the “Company”). This publication contains forward-looking statements, which are not guarantees of future performance and may involve subjective judgment and analysis. As such, there are no assurances that the Company will meet its expectations with respect to its future sales volume or becoming cash flow positive. The information provided herein is believed to be accurate and reliable, however the Company makes no representations or warranties, expressed or implied, as to its accuracy or completeness. The Company has no obligation to provide the recipient with additional updated information. No information in this publication should be interpreted as any indication whatsoever of the Company’s future revenues, results of operations, or stock price.